Cancerous Inhibitor of Protein Phosphatase 2A as a Molecular Marker for Aggressiveness and Survival in Oral Squamous Cell Carcinoma

다국어 초록 (Multilingual Abstract)

Cancerous inhibitor of protein phosphatase 2A (CIP2A) has been identified as one of the most commonly altered proteins in human cancers. It blocks the tumor-suppressive action of protein phosphatase 2A (PP2A) complex and enhances malignancy. Thirty-five patients with squamous cell carcinoma of the oral cavity underwent surgical resection of the tumor. CIP2A was assessed by quantitative real-time PCR in the resected tumor tissues and in their adjacent normal tissues. CIP2A was found to be overexpressed in all oral squamous cell carcinoma (OSCC) specimens in comparison to their surrounding normal tissue. CIP2A overexpression was statistically correlated with poor prognostic feature of the tumor. Thus, a high expression level of CIP2A was associated with shorter survival. In conclusion, CIP2A is upregulated in OSCC, and its overexpression is correlated with aggressiveness of the tumor and poor outcome and survival. It may serve as a prognostic marker of OSCC.
Key Words Cancerous inhibitor of protein phosphatase 2A, Oral squamous cell carcinoma

참고문헌 (Reference)

1 Soofiyani SR, "The role of CIP2A in cancer : a review and update" 96 : 626-633, 2017

2 Kim SH, "The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation" 41 : 3362-3371, 2019

3 Janssens V, "The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells" 12 : 268-287, 2012

4 Sipeky C, "Synergistic interaction of HOXB13 and CIP2A predisposes to aggressive prostate cancer" 24 : 6265-6276, 2018

5 Kokko LL, "Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma" 47 : 510-516, 2011

6 Sontag JM, "Regulation of cell adhesion by PP2A and SV40 small tumor antigen : an important link to cell transformation" 63 : 2979-2991, 2006

7 Birkman EM, "Protein phosphatase 2A(PP2A)inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer" 7 : 698-706, 2018

8 Li Y, "Prognostic significance of CIP2A in esophagogastric junction adenocarcinoma : a study of 65 patients and a meta-analysis" 2019 : 2312439-, 2019

9 Tang M, "Prognostic significance of CIP2A expression in solid tumors : a metaanalysis" 13 : e0199675-, 2018

10 Zhang Q, "Phosphatases: the new brakes for cancer development?" 2012 : 659649-, 2012

11 Huang SH, "Overview of the 8th edition TNM classification for head and neck cancer" 18 : 40-, 2017

12 Liu N, "Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth" 13 : 111-, 2014

13 Gharat SA, "Oral squamous cell carcinoma : current treatment strategies and nanotechnologybased approaches for prevention and therapy" 33 : 363-400, 2016

14 De P, "Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A(CIP2A) : an oncoprotein with many hands" 5 : 4581-4602, 2014

15 Westermarck J, "Multiple pathways regulated by the tumor suppressor PP2A in transformation" 14 : 152-160, 2008

16 Guo B, "Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression" 39 : e102190-, 2020

17 Le Campion ACOV, "Low survival rates of oral and oropharyngeal squamous cell carcinoma" 2017 : 5815493-, 2017

18 Arroyo JD, "Involvement of PP2A in viral and cellular transformation" 24 : 7746-7755, 2005

19 Pickering CR, "Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers" 3 : 770-781, 2013

20 Ma J, "Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control : a metaanalysis" 48 : 1076-1084, 2012

21 Ji J, "Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer" 21 : 307-316, 2018

22 Sablina AA, "Identification of PP2A complexes and pathways involved in cell transformation" 70 : 10474-10484, 2010

23 Agrawal N, "Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1" 333 : 1154-1157, 2011

24 Adel M, "Evaluation of lymphatic and vascular invasion in relation to clinicopathological factors and treatment outcome in oral cavity squamous cell carcinoma" 94 : e1510-, 2015

25 Rajala A, "Developmental and light regulation of tumor suppressor protein PP2A in the retina" 9 : 1505-1523, 2017

26 Liu X, "Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells" 38 : 271-278, 2017

27 Nagaraj NS, "Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth" 17 : 483-493, 2011

28 Khanna A, "Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers" 138 : 525-532, 2016

29 Khanna A, "Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target" 73 : 6548-6553, 2013

30 Austin JA, "Cancerous inhibitor of protein phosphatase 2A(CIP2A)modifies energy metabolism via 5’ AMP-activated protein kinase signalling in malignant cells" 476 : 2255-2269, 2019

31 Liu J, "Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16E7 oncoprotein" 122 : 430-436, 2011

32 Velmurugan BK, "CIP2A overexpression in Taiwanese oral cancer patients" 11 : 2589-2594, 2019

33 Dong QZ, "CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis" 18 : 857-865, 2011

34 Rantanen T, "CIP2A expression and prognostic role in patients with esophageal adenocarcinoma" 30 : 684-, 2013

35 Gao F, "CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells" 40 : 2445-2454, 2018

36 Wu Y, "CIP2A cooperates with H-Ras to promote epithelial-mesenchymal transition in cervical-cancer progression" 356 (356): 646-655, 2015

37 Sangodkar J, "All roads lead to PP2A : exploiting the therapeutic potential of this phosphatase" 283 : 1004-1024, 2016

38 Wang X, "Aberrant expression of vasculogenic mimicry, PRRX1, and CIP2A in clear cell renal cell carcinoma and its clinicopathological significance" 98 : e17028-, 2019

39 Nagelli S, "43P CIP2A as a novel target to combat basal like breast cancer" 30 (30): iii14-iii15, 2019